Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Disturbance of tyrosine and tryptophane metabolism in depression].

Literature DB >> 5508195

[Disturbance of tyrosine and tryptophane metabolism in depression].

W Birkmayer, W Linauer.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1970 PMID： 5508195 DOI： 10.1007/bf00341554

Source DB: PubMed Journal: Arch Psychiatr Nervenkr (1970)

× No keyword cloud information.

15 in total

1. CORRELATIONS BETWEEN BEHAVIORAL VARIABLES AND URINARY 17-HYDROXYCORTICOSTEROIDS IN DEPRESSED PATIENTS.

Authors: W E BUNNEY; J W MASON; D A HAMBURG
Journal: Psychosom Med Date: 1965 Jul-Aug Impact factor: 4.312

2. The spectrophotofluorometric determination of tryptophan in plasma and of tryptophan and tyrosine in protein hydrolysates.

Authors: D E DUGGAN; S UDENFRIEND
Journal: J Biol Chem Date: 1956-11 Impact factor: 5.157

3. Application of paper chromatography to the estimation of free amino acids in tissues.

Authors: J AWAPARA
Journal: Arch Biochem Date: 1948-10

4. Introduction and removal of hydrocortisone from plasma. Rates in normal subjects and anxious patients.

Authors: H PERSKY
Journal: Arch Gen Psychiatry Date: 1962-08

5. Daily rhythm in tyrosine concentration in human plasma: persistence on low-protein diets.

Authors: R J Wurtman; C Chou; C M Rose
Journal: Science Date: 1967-11-03 Impact factor: 47.728

6. [Deficit of essential amino acids in endogenous depression].

Authors: W Birkmayer; E Neumayer; W Stöckl; G Weiler
Journal: Wien Klin Wochenschr Date: 1968-11-08 Impact factor: 1.704

7. Tyrosine metabolism in manic depressive illness.

Authors: R Takahashi; H Utena; Y Machiyama; M Kurihare; T Otsuka; T Nakamura; H Kanamura
Journal: Life Sci Date: 1968-11-15 Impact factor: 5.037

8. Physiologic treatment of depressive reactions: a pilot study.

Authors: H D Kurland
Journal: Am J Psychiatry Date: 1965-10 Impact factor: 18.112

9. Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine.

Authors: J J Schildkraut; E K Gordon; J Durell
Journal: J Psychiatr Res Date: 1965-12 Impact factor: 4.791

10. [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors: W BIRKMAYER; O HORNYKIEWICZ
Journal: Wien Klin Wochenschr Date: 1961-11-10 Impact factor: 1.704

13 in total

1. [Sleep deprivation. Clinical ratings, psychophysiological and biochemical measures (author's transl)].

Authors: M Schmocker; P Baumann; F Reyero; H Heimann
Journal: Arch Psychiatr Nervenkr (1970) Date: 1975-12-31

Review 2. [Biochemistry of depression].

Authors: N Matussek
Journal: J Neural Transm Date: 1972 Impact factor: 3.575

Review 3. [Modern treatment of parkinsonism].

Authors: W Birkmayer; E Neumayer
Journal: Z Neurol Date: 1972

[Disturbance of tyrosine and tryptophane metabolism in depression].

1. CORRELATIONS BETWEEN BEHAVIORAL VARIABLES AND URINARY 17-HYDROXYCORTICOSTEROIDS IN DEPRESSED PATIENTS.

2. The spectrophotofluorometric determination of tryptophan in plasma and of tryptophan and tyrosine in protein hydrolysates.

3. Application of paper chromatography to the estimation of free amino acids in tissues.

4. Introduction and removal of hydrocortisone from plasma. Rates in normal subjects and anxious patients.

5. Daily rhythm in tyrosine concentration in human plasma: persistence on low-protein diets.

6. [Deficit of essential amino acids in endogenous depression].

7. Tyrosine metabolism in manic depressive illness.

8. Physiologic treatment of depressive reactions: a pilot study.

9. Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine.

10. [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

1. [Sleep deprivation. Clinical ratings, psychophysiological and biochemical measures (author's transl)].

Review 2. [Biochemistry of depression].

Review 3. [Modern treatment of parkinsonism].

4. The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome.

5. The tyrosine-tryptophan-diagram in a longtime study with depressed patients.

6. The balance of biogenic amines as condition for normal behaviour.

7. [Orientational study on the plasma tyrosine circadian rhythm in depressive syndromes of various etiology].

8. [Another case of pathological three-phase-rhythm in the course of a diencephalic syndrome].

9. [Serum arginase-activity in manic-depressive illness].

10. Diurnal changes in dopamine-beta-hydroxylase, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in serum of man.